Veritable’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,205
| Closed | -$2.54M | – | 799 |
|
|
2023
Q2 | $2.54M | Sell |
7,205
-130
| -2% | -$43.8K | 0.04% | 201 |
|
|
2023
Q1 | $2.31M | Buy |
7,335
+147
| +2% | +$44.1K | 0.04% | 207 |
|
|
2022
Q4 | $2.08M | Buy |
7,188
+197
| +3% | +$60K | 0.04% | 229 |
|
|
2022
Q3 | $2.02M | Buy |
6,991
+9
| +0.1% | +$2.59K | 0.04% | 219 |
|
|
2022
Q2 | $1.97M | Buy |
6,982
+384
| +6% | +$103K | 0.04% | 242 |
|
|
2022
Q1 | $1.72M | Buy |
6,598
+173
| +3% | +$41.1K | 0.03% | 286 |
|
|
2021
Q4 | $1.41M | Sell |
6,425
-317
| -5% | -$61.6K | 0.02% | 326 |
|
|
2021
Q3 | $1.22M | Sell |
6,742
-125
| -2% | -$24.4K | 0.02% | 334 |
|
|
2021
Q2 | $1.39M | Buy |
6,867
+51
| +0.7% | +$10.7K | 0.02% | 316 |
|
|
2021
Q1 | $1.47M | Buy |
6,816
+702
| +11% | +$154K | 0.02% | 282 |
|
|
2020
Q4 | $1.45M | Sell |
6,114
-495
| -7% | -$114K | 0.03% | 268 |
|
|
2020
Q3 | $1.8M | Sell |
6,609
-44
| -0.7% | -$12.1K | 0.04% | 222 |
|
|
2020
Q2 | $1.93M | Sell |
6,653
-648
| -9% | -$176K | 0.04% | 199 |
|
|
2020
Q1 | $1.74M | Sell |
7,301
-31
| -0.4% | -$7.11K | 0.04% | 203 |
|
|
2019
Q4 | $1.6M | Buy |
7,332
+143
| +2% | +$28.9K | 0.03% | 264 |
|
|
2019
Q3 | $1.22M | Buy |
7,189
+76
| +1% | +$13.4K | 0.02% | 312 |
|
|
2019
Q2 | $1.3M | Sell |
7,113
-60
| -0.8% | -$10.5K | 0.03% | 292 |
|
|
2019
Q1 | $1.32M | Buy |
7,173
+183
| +3% | +$33.8K | 0.03% | 289 |
|
|
2018
Q4 | $1.16M | Sell |
6,990
-303
| -4% | -$52.5K | 0.03% | 295 |
|
|
2018
Q3 | $1.41M | Buy |
7,293
+412
| +6% | +$73.4K | 0.03% | 281 |
|
|
2018
Q2 | $1.17M | Buy |
6,881
+455
| +7% | +$70.5K | 0.03% | 306 |
|
|
2018
Q1 | $1.05M | Buy |
6,426
+330
| +5% | +$53.9K | 0.02% | 324 |
|
|
2017
Q4 | $914K | Sell |
6,096
-280
| -4% | -$41.5K | 0.02% | 354 |
|
|
2017
Q3 | $969K | Buy |
6,376
+29
| +0.5% | +$4.37K | 0.02% | 353 |
|
|
2017
Q2 | $818K | Buy |
6,347
+1,858
| +41% | +$224K | 0.02% | 395 |
|
|
2017
Q1 | $491K | Buy |
4,489
+174
| +4% | +$15.3K | 0.01% | 494 |
|
|
2016
Q4 | $318K | Sell |
4,315
-2,444
| -36% | -$199K | 0.01% | 581 |
|
|
2016
Q3 | $589K | Buy |
6,759
+628
| +10% | +$59.3K | 0.01% | 430 |
|
|
2016
Q2 | $527K | Buy |
6,131
+2,112
| +53% | +$182K | 0.01% | 441 |
|
|
2016
Q1 | $319K | Sell |
4,019
-4,152
| -51% | -$376K | 0.01% | 554 |
|
|
2015
Q4 | $1.03M | Buy |
8,171
+143
| +2% | +$17.3K | 0.03% | 309 |
|
|
2015
Q3 | $836K | Buy |
8,028
+1,621
| +25% | +$208K | 0.02% | 329 |
|
|
2015
Q2 | $791K | Sell |
6,407
-1,428
| -18% | -$180K | 0.02% | 357 |
|
|
2015
Q1 | $924K | Buy |
7,835
+539
| +7% | +$64.6K | 0.02% | 427 |
|
|
2014
Q4 | $867K | Sell |
7,296
-288
| -4% | -$32.4K | 0.02% | 443 |
|
|
2014
Q3 | $852K | Sell |
7,584
-505
| -6% | -$48.1K | 0.02% | 448 |
|
|
2014
Q2 | $766K | Sell |
8,089
-128
| -2% | -$8.98K | 0.02% | 477 |
|
|
2014
Q1 | $581K | Sell |
8,217
-163
| -2% | -$12.9K | 0.01% | 542 |
|
|
2013
Q4 | $623K | Buy |
8,380
+1,040
| +14% | +$72.4K | 0.01% | 515 |
|
|
2013
Q3 | $557K | Buy |
7,340
+495
| +7% | +$39.4K | 0.01% | 543 |
|
|
2013
Q2 | $548K | Buy |
+6,845
| New | +$504K | 0.01% | 548 |
|